…。此行动应涵盖欧洲殴打癌症计划的第六个旗舰计划:“所有人的癌症诊断和治疗”计划,并将基于其他EU4Health计划资助的项目的结果:所有工会公民的个性化癌症医学(PCM4EU)(PCM4EU)50,欧盟癌症和公共卫生基因组计划的项目,以及诊断的项目,以及Ac.heal and aC.Heal and acive for acive for acive the Inairotiel and acive for acive for acive for acive the acive and。在Nopho-DBShip联盟中治疗的白血病,这是跨欧洲的合作(CHIP-AML22)。个性化医学的项目和主要计划,例如国际个性化医学联盟(ICPERMED),1+百万个基因组倡议,欧洲范围内加速数据驱动的癌症研究(EOSC4CASCER)的基础(EOSC4CASCER)以及欧洲个性化医学伙伴关系(欧洲的抗击癌症计划行动)。
1Https://www.ema.europa.eu/en/human-neculatory-everview/research-development/clinical-clinical-trials-human-medicines/acceleration-celererating-clinical-clinical-clinical-trials-eu-eu-act-eu 2 https://www.ema.europa.eu/en/human-neculatory-everview/advanced-therapy-medicinal-products-overview。3 https://health.ec.europa.eu/non-communicable-diseases/cancer/europes-beating-cancer-cancer-plan-plan-eu4health-fence--项目/项目/PCM4EU_EN#:〜:text = PCM4EU%20%2D%20psersanalishis%20CANCER%20cancer%20medicine%20MED 20FOR%20ELL%20EU%20EU%20Citizens&text = as%20pcm%20IS%20IS%20Bas ED%20BAS ED%20ON,实施%20OF%20of%20 F%20PCM%20PCM%20PCM%20PCM%20PCM%20PCM%20。3 https://health.ec.europa.eu/non-communicable-diseases/cancer/europes-beating-cancer-cancer-plan-plan-eu4health-fence--项目/项目/PCM4EU_EN#:〜:text = PCM4EU%20%2D%20psersanalishis%20CANCER%20cancer%20medicine%20MED 20FOR%20ELL%20EU%20EU%20Citizens&text = as%20pcm%20IS%20IS%20Bas ED%20BAS ED%20ON,实施%20OF%20of%20 F%20PCM%20PCM%20PCM%20PCM%20PCM%20PCM%20。
